The incidence of hydrocephalus among patients with and without spinal muscular atrophy (SMA): Results from a US electronic health records study

Abstract Background The incidence of hydrocephalus in the spinal muscular atrophy (SMA) population relative to the general population is currently unknown. Since the approval of nusinersen, an intrathecally administered drug for SMA, a small number of hydrocephalus cases among nusinersen users have...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Emma Viscidi, Nasha Wang, Maneesh Juneja, Ishir Bhan, Claudia Prada, Dayle James, Stacie Lallier, Corinne Makepeace, Karen Laird, Susan Eaton, Anne Dilley, Susan Hall
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2021-05-01
Edice:	Orphanet Journal of Rare Diseases
Témata:	Spinal muscular atrophy Hydrocephalus Nusinersen
On-line přístup:	https://doi.org/10.1186/s13023-021-01822-4
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!